Clinical Trials Logo

Right Ventricular Dysfunction clinical trials

View clinical trials related to Right Ventricular Dysfunction.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT05172115 Terminated - Pulmonary Embolism Clinical Trials

Catheter-Directed Thrombolysis Versus Anticoagulation Monotherapy in Intermediate-High Risk PE

CANARY
Start date: December 22, 2018
Phase: Phase 3
Study type: Interventional

In an open-label parallel groups blinded-endpoint randomized clinical trial, the investigators aim to assess the safety and efficacy of conventional catheter-directed thrombolysis (CDT) vs anticoagulation monotherapy on outcomes of patients with acute intermediate-high risk pulmonary embolism. The investigators hypothesize that CDT will have a superior efficacy and safety compared with anticoagulation-only therapy regarding the proportion of patients with a right ventricle to left ventricle (RV/LV) ratio > 0.9 at a 3-month follow-up by an imaging core laboratory, major bleeding, severe thrombocytopenia, or vascular access complication.

NCT ID: NCT03988842 Terminated - Pulmonary Embolism Clinical Trials

Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism

SAFE-LYSE
Start date: July 25, 2019
Phase: Phase 4
Study type: Interventional

The purpose of this study is to examine the degree to which pulmonary embolism (clot) can be dissolved when treated with a very low dose of a systemic thrombolytic drug (clot buster) along with standard anticoagulant therapy as compared to the standard of care anticoagulant therapy alone.

NCT ID: NCT03032900 Terminated - Clinical trials for Right Ventricular Dysfunction

Right Ventricular Dysfunction Incidence After Major Lung Resection

RESECHO
Start date: January 1, 2017
Phase:
Study type: Observational

This study aims to describe incidence of right ventricular dysfunction after major lung resection with echocardiography criteria.